Steve Elms - Net Worth and Insider Trading
Steve Elms Net Worth
The estimated net worth of Steve Elms is at least $16 Million dollars as of 2024-04-26. Steve Elms is the Director of ADMA Biologics Inc and owns about 2,192,112 shares of ADMA Biologics Inc (ADMA) stock worth over $14 Million. Steve Elms is also the Director of Marker Therapeutics Inc and owns about 315,988 shares of Marker Therapeutics Inc (MRKR) stock worth over $1 Million. Details can be seen in Steve Elms's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steve Elms has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).
Transaction Summary of Steve Elms
Steve Elms Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steve Elms owns 18 companies in total, including Zosano Pharma Corp (ZSANQ) , ADMA Biologics Inc (ADMA) , and Marker Therapeutics Inc (MRKR) among others .
Click here to see the complete history of Steve Elms’s form 4 insider trades.
Insider Ownership Summary of Steve Elms
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZSANQ | Zosano Pharma Corp | 2019-04-11 | 10 percent owner |
| ADMA | ADMA Biologics Inc | 2024-03-19 | director |
| MRKR | Marker Therapeutics Inc | 2021-03-16 | director |
| SNSS | Sunesis Pharmaceuticals Inc | 2019-07-15 | 10 percent owner |
| LOXO | Loxo Oncology Inc | 2019-02-15 | director & 10 percent owner |
| SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | 10 percent owner |
| AGRX | Agile Therapeutics Inc | 2014-05-23 | 10 percent owner |
| PTXTQ | Pernix Therapeutics Holdings Inc | 2016-05-26 | director |
| VRAYQ | ViewRay Inc | 2016-03-30 | 10 percent owner |
| ASXC | Asensus Surgical Inc | 2013-12-06 | 10 percent owner |
| TTOO | T2 Biosystems Inc | 2015-12-09 | director & 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2015-04-23 | 10 percent owner |
| CDTX | Cidara Therapeutics Inc | 2015-04-20 | director |
| ARAV | Aravive Inc | 2015-01-27 | 10 percent owner |
| ZLTQ | ZELTIQ Aesthetics Inc | 2014-01-23 | 10 percent owner |
| MLNTQ | Melinta Therapeutics Inc | 2012-02-07 | 10 percent owner |
| VIRX | Viracta Therapeutics Inc | 2019-01-23 | 10 percent owner |
| ELEV | Elevation Oncology Inc | 2021-06-24 | director & other: Managing Member |
Steve Elms Latest Holdings Summary
Steve Elms currently owns a total of 2 stocks. Among these stocks, Steve Elms owns 2,192,112 shares of ADMA Biologics Inc (ADMA) as of March 19, 2024, with a value of $14 Million and a weighting of 91.18%. Steve Elms also owns 315,988 shares of Marker Therapeutics Inc (MRKR) as of March 16, 2021, with a value of $1 Million and a weighting of 8.82%.
Latest Holdings of Steve Elms
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMA | ADMA Biologics Inc | 2024-03-19 | 2,192,112 | 6.56 | 14,375,870 |
| MRKR | Marker Therapeutics Inc | 2021-03-16 | 315,988 | 4.40 | 1,390,347 |
Holding Weightings of Steve Elms
Steve Elms Form 4 Trading Tracker
According to the SEC Form 4 filings, Steve Elms has made a total of 2 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ADMA Biologics Inc is the sale of 461,716 shares on March 19, 2024, which brought Steve Elms around $3 Million.
According to the SEC Form 4 filings, Steve Elms has made a total of 1 transactions in Marker Therapeutics Inc (MRKR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Marker Therapeutics Inc is the acquisition of 114,286 shares on March 16, 2021, which cost Steve Elms around $2 Million.
Insider Trading History of Steve Elms
- 1
Steve Elms Trading Performance
GuruFocus tracks the stock performance after each of Steve Elms's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steve Elms is 75.27%. GuruFocus also compares Steve Elms's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steve Elms within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steve Elms's insider trading performs compared to the benchmark.
Performance of Steve Elms
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.22 | 75.27 | -3.76 | -77.75 | -67.21 | -38.01 |
| Relative Return to S&P 500(%) | 4.6 | 68.68 | -16.66 | -87.72 | -67.18 | -46.91 |
Steve Elms Ownership Network
Ownership Network List of Steve Elms
Ownership Network Relation of Steve Elms
Steve Elms Owned Company Details
What does Zosano Pharma Corp do?
Who are the key executives at Zosano Pharma Corp?
Steve Elms is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .
Zosano Pharma Corp (ZSANQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zosano Pharma Corp Insider Transactions
Steve Elms Mailing Address
Above is the net worth, insider trading, and ownership report for Steve Elms. You might contact Steve Elms via mailing address: 888 Seventh Ave, 29th Fl, New York Ny 10106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
